NL-OMON21802
Not yet recruiting
Not Applicable
Allogeneic Bone Marrow Derived Mesenchymal Stromal Cells for the Treatment of Refractory Proctitis in Ulcerative Colitis
eiden University Medical Center0 sites14 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- eiden University Medical Center
- Enrollment
- 14
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •a)Men and women ≥ 18 years of age;
- •b)Patient must have UC confirmed by endoscopic and histologic evidence;
Exclusion Criteria
- •a)Patients suffering from renal\- or hepatic failure;
- •b)Use of any investigational drug within 1 month prior to screening or within 5 half\-lives of the investigational agent, whichever is longer;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Mesenchymal Stromal Cells for the treatment of Ulcerative Colitislcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856Therapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2017-003524-75-NLeiden University Medical Center14
Recruiting
Phase 2
Allogeneic bone marrow derived mesenchymal stromal cells for the treatment of refractory proctitis in Ulcerative ColitisUlcerative Colitis10017969NL-OMON48876eids Universitair Medisch Centrum14
Completed
Not Applicable
Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients with Refractory Perianal Crohn*s DiseasefistulaM. Crohn10017969NL-OMON36386eids Universitair Medisch Centrum21
Active, not recruiting
Not Applicable
Allogeneic Bone Marrow Derived Mesenchymal Stem Cellsfor the Treatment of Fistulas in Patients withRefractory Perianal Crohn’s Disease - allo bmMSCs CD fistulaEUCTR2009-015680-14-NLeiden University Medical Center
Active, not recruiting
Phase 1
Safety of bone marrow-derived stem cells in treatment of knee cartilage defects.EUCTR2018-004067-31-CZBioinova, s.r.o.6